U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H22O2
Molecular Weight 270.3661
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOHEXESTROL

SMILES

CC[C@H]([C@@H](CC)C1=CC=C(O)C=C1)C2=CC=C(O)C=C2

InChI

InChIKey=PBBGSZCBWVPOOL-ROUUACIJSA-N
InChI=1S/C18H22O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,17-20H,3-4H2,1-2H3/t17-,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H22O2
Molecular Weight 270.3661
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25349334 | https://www.ncbi.nlm.nih.gov/pubmed/23013281 | https://www.ncbi.nlm.nih.gov/pubmed/6267445 | https://www.ncbi.nlm.nih.gov/pubmed/5641522

Isohexestro is a synthetic, non-steroidal estrogen of the stilbestrol group related to diethylstilbestrol, that shown to be inhibitors of microtubule assembly in vitro.

Originator

Sources: Acta Endocrinologica, Volume 53, Issue 1, Pages 84-92, Journal, 1966

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.0 µM [IC50]
Target ID: P02771
Gene ID: 174.0
Gene Symbol: AFP
Target Organism: Homo sapiens (Human)
0.008 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Endocrine disruption screening by protein and gene expression of vitellogenin in freshly isolated and cryopreserved rainbow trout hepatocytes.
2014-08-18
Robust array-based coregulator binding assay predicting ERα-agonist potency and generating binding profiles reflecting ligand structure.
2013-03-18
Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities.
2012-11-19
Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
2012-02
Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.
2010-12-05
Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
2010-08
The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
2010-08
Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
2010-08
Diethylstilbestrol and other nonsteroidal estrogens: novel class of store-operated calcium channel modulators.
2010-05
Synthesis and applications of diethylstilbestrol-based molecularly imprinted polymer-coated hollow fiber tube.
2010-03-17
Determination of anabolic steroids in bovine urine by liquid chromatography-tandem mass spectrometry.
2009-08-01
[Effects of Yi Fu Ning soft gelatin capsules on reproductive endocrine-immune function of ovariectomized rats].
2009-07
Towards high-throughput identification of endocrine disrupting compounds with mass spectrometry.
2009-06
[Determination of hormone multi-residues in animal tissues by gas chromatography-mass spectrometry].
2009-05
Development of a rapid method for the analysis of synthetic growth promoters in bovine muscle using liquid chromatography tandem mass spectrometry.
2009-04-01
Biochemical and structural characterization of a short-chain dehydrogenase/reductase of Thermus thermophilus HB8: a hyperthermostable aldose-1-dehydrogenase with broad substrate specificity.
2009-03-16
Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress.
2009-03-16
Structure of the G225P/G226P mutant of mouse 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) ternary complex: implications for the binding of inhibitor and substrate.
2009-03
Treatments for suppression of lactation.
2009-01-21
[Hexestrol inhibits ATP-induced contractile response of isolated preparations of pregnant human uterus].
2009-01-15
In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin.
2009-01-01
Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
2009-01
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer.
2009
Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formation.
2008-09
Dipotassium 4,4'-(hexane-3,4-di-yl)bis-(benzene-sulfonate) dihydrate.
2008-07-16
Effects of hexestrol on mouse ovarian morphology and ovulation.
2008-06-20
Development and in-house validation of an LC-MS/MS method for the determination of stilbenes and resorcylic acid lactones in bovine urine.
2008-06
Synthesis of [4.6.4.6]fenestradienes and [4.6.4.6]fenestrenes based on an 8pi-6pi-cyclization-oxidation cascade.
2008-04-16
Determination of estrogens in wastewater using three-phase hollow fiber-mediated liquid-phase microextraction followed by HPLC.
2008-03
Studies on thermal reactivity of beta-(1,2-allenyl)butenolides and 2-allyl-3-allenylcyclohex-2-enones.
2008
Activity of xenoestrogens at nanomolar concentrations in the E-Screen assay.
2007-12
Comparison of time-resolved fluoroimmunoassay for determining hexoestrol residues in chicken muscle tissues based on polyclonal antibodies with liquid chromatography and tandem mass spectrometry.
2007-09-08
Interactions of diethylstilbestrol (DES) and DES analogs with membrane progestin receptor-alpha and the correlation with their nongenomic progestin activities.
2007-07
A new molecularly imprinted polymer for the on-column solid-phase extraction of diethylstilbestrol from aqueous samples.
2007-07
Simultaneous determination of residual stilbenes and stilbene metabolites in animal tissue by liquid chromatography-tandem mass spectrometry.
2007-06-01
Determination of synthetic hormones in animal urine by high-performance liquid chromatography/mass spectrometry.
2007-05-04
HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans.
2007-02
The use of liquid membranes in the multi-residue extraction of stilbenes in a variety of biological matrices and their detection with LC-ES-MS.
2007-01-16
Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
2006-11
Development and validation of a fluorescence HPLC-based screening assay for inhibition of human estrogen sulfotransferase.
2006-10-01
[Determination of residues of three stilbene drugs in animal tissues using gas chromatography-mass spectrometry].
2006-09
Determination of hexoestrol residues in animal tissues based on enzyme-linked immunosorbent assay and comparison with liquid chromatography-tandem mass spectrometry.
2006-06-07
Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.
2006-06
Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family.
2006-03
Cellular and molecular regulation of the primate endometrium: a perspective.
2006
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.
1997-03
Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells.
1996-01-15
Subacute toxicity of diethylstilboestrol and hexoestrol in the female rat, and the effects of clomiphene pretreatment.
1988-03
Carcinogenicity and metabolic activation of hexestrol.
1985-10
Clear-cell adenocarcinoma of the genital tract in young females. Registry report.
1972-12-21
Patents

Sample Use Guides

80 mkg/day
Route of Administration: Other
Immediately prior to the assay, a reaction mixture containing 45 mL of HNG buffer, 450 μL of ovalbumin, 75 μL of rat amniotic fluid, and 45 μL of 1 × 10−6 M 2,4,6,7-[3H]-estrone was prepared. Increasing concentrations of radioinert Isohexestrol (10 μL) were incubated with 2 mL of the reaction mixture in 13 × 100 mm borosilicate glass tubes at room temperature for 30 min. Tubes were subsequently transferred to ice and refrigerated (4 °C) for 1 h. While constantly being stirred, 200 μL of the cold HNG-charcoal suspension was added to each assay tube after the final incubation period. Tubes were vortexed and immediately centrifuged at 1,400g for 15 min at 4 °C. Following centrifugation, a 1 mL aliquot of the supernatant was removed from each tube and transferred to a scintillation vial containing 10 mL of Ultima Gold liquid scintillation cocktail, and the radioactivity was counted on a Packard Tri-Carb 1600 TR Liquid Scintillation Analyzer
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:44:09 GMT 2025
Edited
by admin
on Mon Mar 31 18:44:09 GMT 2025
Record UNII
O4EC35PE92
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-35752
Preferred Name English
ISOHEXESTROL
Common Name English
PHENOL, 4,4'-(1,2-DIETHYLETHYLENE)DI-, (±)-
Systematic Name English
DL-HEXESTROL
Common Name English
SINESTROL
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2182
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
Code System Code Type Description
NSC
35752
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY
PUBCHEM
234907
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY
CAS
5776-72-7
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID501201246
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY
FDA UNII
O4EC35PE92
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY
NCI_THESAURUS
C95318
Created by admin on Mon Mar 31 18:44:09 GMT 2025 , Edited by admin on Mon Mar 31 18:44:09 GMT 2025
PRIMARY